Fareed J, Hoppensteadt D, Jeske W, Clarizio R, Walenga JM. Low Molecular Weight Heparins. Are They Different?Can J Cardiol1998;14(Suppl E):28E.
2.
Bick RL, Fareed J.Low Molecular Weight Heparin: Differences and Similarities in Approved Preparations in the United States. Clin Appl Throm Hemost1999;5(Suppl 1):S63.
3.
Fareed J, Walenga JM, Racanelli A, Hoppensteadt D, Huan X, Messmore HL. Validity of the newly established low-molecular-weight heparin standard in cross-referencing low-molecular-weight heparins. Haemostasis1988;18(Suppl 3):33.
4.
American Society of Hospital Pharmacists. ASHP statement on the formulary system. Am J Hosp Pharm1988;43:2839.
5.
Nightingale SL. From the Food and Drug Administration. JAMA1993;270(14):1672.
6.
Merli G, Vanscoy G, et al.Applying scientific criteria to therapeutic interchange: A balanced analysis of low molecular weight heparins. J Thromb Thrombolysis2001;11(3):247.
7.
McCart GM, Kayser S.Therapeutic equivalency of low molecular weight heparins. Ann Pharmcotherap2002;36:1042.
8.
Messmore HL, Coyne E, Wehrmacher WH, Demir AM, Fareed J.Studies comparing low molecular weight heparin with heparin for the treatment of thromboembolism: A literature review. Curr Pharm Des2004;10:1001.
9.
Prandoni P.Low molecular weight heparins: Are they interchangeable? Yes. J Thromb Hemostasis2003;1:10.
10.
Nenci G.Low molecular weight heparins: Are they interchangeable? No. J Thromb Hemostasis2003;1:12.
11.
The Wall Street Journal. Thursday, June 12, 2003. Page A3, Vol. CCXLI 114. Bush Acts to Speed Generics to Market (Leila Abboud).
12.
Fareed J, Bick RL. Are the current guidelines of generic low molecular weight heparins adequate?Clin Appl Thromb Hemost2003;9(4):273.
13.
Leong W, Hoppensteadt DA. Generic forms of low molecular weight heparins: Some practical considerations. Clin Appl Thromb Hemost2003;9(4):293.
14.
Fareed J, Hoppensteadt DA, Schultz C, Ma Q, Florian M, Neville B, Messmore HL. Curr Pharm Des2004;20:983.